BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 2266130)

  • 1. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.
    Urata H; Kinoshita A; Misono KS; Bumpus FM; Husain A
    J Biol Chem; 1990 Dec; 265(36):22348-57. PubMed ID: 2266130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch.
    Takai S; Shiota N; Yamamoto D; Okunishi H; Miyazaki M
    Life Sci; 1996; 58(7):591-7. PubMed ID: 8632712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart.
    Kinoshita A; Urata H; Bumpus FM; Husain A
    J Biol Chem; 1991 Oct; 266(29):19192-7. PubMed ID: 1918036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.
    Urata H; Boehm KD; Philip A; Kinoshita A; Gabrovsek J; Bumpus FM; Husain A
    J Clin Invest; 1993 Apr; 91(4):1269-81. PubMed ID: 7682566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system.
    Nishimura H; Buikema H; Baltatu O; Ganten D; Urata H
    Am J Physiol; 1998 Oct; 275(4):H1307-12. PubMed ID: 9746480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries.
    Richard V; Hurel-Merle S; Scalbert E; Ferry G; Lallemand F; Bessou JP; Thuillez C
    Circulation; 2001 Aug; 104(7):750-2. PubMed ID: 11502696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
    Urata H; Ganten D
    Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of chymase from human vascular tissues.
    Takai S; Shiota N; Sakaguchi M; Muraguchi H; Matsumura E; Miyazaki M
    Clin Chim Acta; 1997 Sep; 265(1):13-20. PubMed ID: 9352125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin I conversion by human and rat chymotryptic proteinases.
    Wintroub BU; Schechter NB; Lazarus GS; Kaempfer CE; Schwartz LB
    J Invest Dermatol; 1984 Nov; 83(5):336-9. PubMed ID: 6092480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymase-dependent angiotensin II formation in human vascular tissue.
    Takai S; Jin D; Sakaguchi M; Miyazaki M
    Circulation; 1999 Aug; 100(6):654-8. PubMed ID: 10441104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of angiotensin I to angiotensin II by chymase activity in human pulmonary membranes.
    Lindberg BF; Gyllstedt E; Andersson KE
    Peptides; 1997; 18(6):847-53. PubMed ID: 9285934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme.
    Ahmad S; Varagic J; VonCannon JL; Groban L; Collawn JF; Dell'Italia LJ; Ferrario CM
    Biochem Biophys Res Commun; 2016 Sep; 478(2):559-64. PubMed ID: 27465904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity.
    Kokkonen JO; Saarinen J; Kovanen PT
    Circulation; 1997 Mar; 95(6):1455-63. PubMed ID: 9118513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta.
    Takai S; Shiota N; Kobayashi S; Matsumura E; Miyazaki M
    FEBS Lett; 1997 Jul; 412(1):86-90. PubMed ID: 9257695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin I converting enzyme and chymase in cardiovascular tissues.
    Nishimura H; Hoffmann S; Baltatu O; Sugimura K; Ganten D; Urata H
    Kidney Int Suppl; 1996 Jun; 55():S18-23. PubMed ID: 8743505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chymase: its pathophysiological roles and inhibitors.
    Fukami H; Okunishi H; Miyazaki M
    Curr Pharm Des; 1998 Dec; 4(6):439-53. PubMed ID: 10197055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart.
    Shiota N; Fukamizu A; Takai S; Okunishi H; Murakami K; Miyazaki M
    J Hypertens; 1997 Apr; 15(4):431-40. PubMed ID: 9211178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue angiotensin II system in the human heart.
    Urata H; Hoffmann S; Ganten D
    Eur Heart J; 1994 Dec; 15 Suppl D():68-78. PubMed ID: 7713117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation.
    Sanker S; Chandrasekharan UM; Wilk D; Glynias MJ; Karnik SS; Husain A
    J Biol Chem; 1997 Jan; 272(5):2963-8. PubMed ID: 9006943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of the gene and cDNA for human heart chymase.
    Urata H; Kinoshita A; Perez DM; Misono KS; Bumpus FM; Graham RM; Husain A
    J Biol Chem; 1991 Sep; 266(26):17173-9. PubMed ID: 1894611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.